Aspirin vs Pembrolizumab

## Aspirin vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between **Aspirin** and **Pembrolizumab**.

## Mechanism of Action

**Aspirin**: Irreversibly inhibits cyclooxygenase-1 and -2.

**Pembrolizumab**: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

## Pharmacokinetics

**Half-life**: Aspirin — 2-3 hours; Pembrolizumab — 26 days.

## Chemical Properties

**Molecular Formula**: Aspirin — C9H8O4; Pembrolizumab — N/A.

**Molecular Weight**: Aspirin — 180.1580 g/mol; Pembrolizumab — N/A.

**Type**: Aspirin — Small molecule; Pembrolizumab — Antibody.